A new narrative review looked at the pathways that may carry fluid and waste out of the brain. These include meningeal lymphatic vessels, a route through the cribriform plate and nasal mucosa, spaces around cranial nerves, the nasopharyngeal lymphatic plexus, cervical lymphatic vessels, and deep cervical lymph nodes. The review focused on whether these routes clear specific proteins such as amyloid beta, tau, and alpha synuclein, which are linked to neurodegenerative diseases.
The review found that evidence for these clearance routes is uneven. Some routes have more support than others, and for individual proteins the evidence is mostly from animal studies or indirect human data. The review did not report on patient populations, sample sizes, or safety outcomes.
The main reason to be careful is that this is a narrative review, not a new clinical trial. It does not provide proof that these pathways work the same way in people or that targeting them would treat disease. The authors note that evidence remains predominantly preclinical or indirect.
For readers, this means the science of brain waste clearance is still developing. It is an active area of research, but it is too early to draw conclusions about preventing or treating conditions like Alzheimer's or Parkinson's disease based on these findings.
